Verfasser: |
Koopmans, Anne B.
Vinkers, David J.
Poulina, Igmar T.
Gelan, Petra J. A.
van Schaik, Ron H. N.
Hoek, Hans W.
van Harten, Peter N. |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2018 |
Reihe/Periodikum: |
Koopmans , A B , Vinkers , D J , Poulina , I T , Gelan , P J A , van Schaik , R H N , Hoek , H W & van Harten , P N 2018 , ' No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness ' , Frontiers in Psychiatry , vol. 9 , 349 . https://doi.org/10.3389/fpsyt.2018.00349 |
Schlagwörter: |
CYP2D6
/ severe mental illness (SMI)
/ guidelines
/ dose adjustment
/ genotyping
/ psychopharmacology
/ personalized medicine
/ CURACAO EXTRAPYRAMIDAL SYNDROMES
/ TARDIVE-DYSKINESIA
/ RATING-SCALE
/ INDUCED AKATHISIA
/ SCHIZOPHRENIA
/ PHARMACOGENETICS
/ ANTIPSYCHOTICS
/ 2D6
/ POLYMORPHISMS |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-28974931 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://cris.maastrichtuniversity.nl/en/publications/e60db623-dc15-4de5-8021-17338c2a3f15 |